PRNewsWire
17 Aug 2026, 02:00 UTC · 3h ago
Cognizant and Benchling Selected as Partners to Accelerate Kyowa Kirin's R&D
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

PRNewsWire
17 Aug 2026, 02:00 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims
3 claims · each scored for market impact
Kyowa Kirin is implementing the Benchling AI platform across its Tokyo and Fuji Research Parks to automate drug discovery and R&D workflows. — Accelerating the R&D cycle and improving candidate selection efficiency generally increases the long-term probability of drug pipeline success.
+0.30Cognizant has been selected as the implementation partner to manage the end-to-end deployment, data migration, and maintenance of the platform for Kyowa Kirin. — Secures a high-value AI-transformation contract for Cognizant, demonstrating their capability in the specialized biopharma vertical.
+0.20Kyowa Kirin is shifting its R&D financial model from large capital expenditures to flexible operating expenses via a single contract for these services. — Improves short-term cash flow predictability and balance sheet flexibility by moving CAPEX to OPEX.
+0.10Which stocks this story touches
Continue reading
6 related stories
Search tags
Cognizant secured a partnership to implement Benchling's AI platform for Kyowa Kirin.
Kyowa Kirin is upgrading its R&D productivity and drug discovery foundation through AI integration.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
Business Wire
7h ago